Weber E H, Gottschlich S, Lippert B M, Görögh T, Folz B J, Eggers S, Werner J A
Klinik für Hals-, Nasen-, und Ohrenheilkunde, Kopf-und Halschirurgie, Christian-Albrechts-Universität Kiel.
Laryngorhinootologie. 1998 Jan;77(1):43-7. doi: 10.1055/s-2007-996929.
mRNA expression of healthy and malignant cells can be compared to each other by employing the "differential display" (DD) technique. Most studies describe sequence analysis of differentially expressed fragments after reamplification by a second round of PCR and subsequent molecular cloning to gain a sufficient amount of DNA for sequencing. The aim of this study was to show whether a sufficient amount of differentially expressed mRNA of squamous cell carcinoma cells of the head and neck region can be generated by PCR alone without cloning steps.
mRNA isolated from cultivated keratinocytes and squamous cell carcinoma cells was reverse transcribed into cDNA which was amplified with PCR. Differentially expressed fragments detected after gel electrophoresis were isolated from the gel and reamplified in a second PCR. The resulting cDNA amounts of the second PCR were suitable for cloning but not for direct sequencing. A third round of PCR with the undiluted final product of the second PCR as template regularly failed. Dilutions of the second PCR products between 1:10 and 1:10(10) were prepared. The third round of PCR was carried out with these various template concentrations.
A sufficient amount of differentially expressed fragments for sequencing procedures resulted when dilutions of the second PCR products ranging from 1:10(2) to 1:10(7) were used as templates in the third round of PCR.
Modifications of PCR parameters provide high DNA copy numbers of differentially expressed mRNA fragments from squamous cell carcinoma cells of the upper aerodigestive tract in amounts that are needed for sequence analysis. This may make it possible to avoid labor-intensive cloning procedures requiring high safety standards.
通过采用“差异显示”(DD)技术,可以比较健康细胞和恶性细胞的mRNA表达。大多数研究描述了在第二轮PCR重新扩增以及随后的分子克隆后,对差异表达片段进行序列分析,以获得足够量的DNA用于测序。本研究的目的是表明,是否仅通过PCR就能产生足够量的头颈部区域鳞状细胞癌细胞差异表达的mRNA,而无需克隆步骤。
从培养的角质形成细胞和鳞状细胞癌细胞中分离的mRNA被逆转录成cDNA,然后用PCR进行扩增。凝胶电泳后检测到的差异表达片段从凝胶中分离出来,并在第二轮PCR中重新扩增。第二轮PCR得到的cDNA量适合克隆,但不适合直接测序。以第二轮PCR的未稀释终产物为模板进行第三轮PCR通常失败。制备了第二轮PCR产物1:10至1:10(10)的稀释液。用这些不同的模板浓度进行第三轮PCR。
当第二轮PCR产物1:10(2)至1:10(7)的稀释液作为第三轮PCR的模板时,产生了足够量的用于测序程序的差异表达片段。
PCR参数的修改可提供来自上呼吸道消化道鳞状细胞癌细胞差异表达的mRNA片段的高DNA拷贝数,其数量为序列分析所需。这可能使得避免需要高安全标准的劳动密集型克隆程序成为可能。